O-18 The EC85 derived from the oral bradykinin B2 receptor antagonist PHA121 against bradykinin effects in healthy volunteers predicts the onset and duration of its clinical effects in Hereditary Angioedema. This evidence concerns the gene BDKRB2 and hereditary angioedema.